Login / Signup
Meltem Yazla
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 4
Top Topics
Early Stage
Respiratory Syndrome Coronavirus
Clinical Practice
Patient Reported Outcomes
Top Venues
Infectious diseases & clinical microbiology
Biomarkers in medicine
Future microbiology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Meyha Sahin
,
Meltem Yazla
Change in Rates of HBsAg and Anti-HBs in Şırnak 20 Years After Introduction of Hepatitis B Vaccine into Routine Infant Immunization Program.
Infectious diseases & clinical microbiology
5 (2) (2023)
Meyha Sahin
,
Meltem Yazla
Change in Rates of HBsAg and Anti-HBs in Şırnak 20 Years After Introduction of Hepatitis B Vaccine into Routine Infant Immunization Program.
Infectious diseases & clinical microbiology
5 (2) (2023)
Gülşah Tunçer
,
Serkan Sürme
,
Osman Faruk Bayramlar
,
Hatice K Karanalbant
,
Betul Copur
,
Meltem Yazla
,
Esra Zerdali
,
Inci Yilmaz Nakir
,
Ayse Ruhkar Kurt Cinar
,
Ahmet Buyukyazgan
,
Hatice Balli
,
Yesim Kurekci
,
Serap Şimşek Yavuz
,
Mehmet M Sonmez
,
Gonul Sengoz
,
Filiz Pehlivanoglu
National Early Warning Score 2 and laboratory predictors correlate with clinical deterioration in hospitalized patients with COVID-19.
Biomarkers in medicine
15 (11) (2021)
Serkan Sürme
,
Gülşah Tunçer
,
Betul Copur
,
Esra Zerdali
,
Inci Yilmaz Nakir
,
Meltem Yazla
,
Osman Faruk Bayramlar
,
Ahmet Buyukyazgan
,
Ayse Ruhkar Kurt Cinar
,
Hatice Balli
,
Yesim Kurekci
,
Filiz Pehlivanoglu
,
Gonul Sengoz
Comparison of clinical, laboratory and radiological features in confirmed and unconfirmed COVID-19 patients.
Future microbiology
16 (2021)